FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to pharmaceutics and medicine, and concerns a combination showing IAP inhibitor and FLT3 inhibitor activity containing (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-(4-fluorobenzoyl)thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylaminopropionamide, the compound of formula
, a method of treating of acute myeloid leukemia, applying said combination for treating acute myeloid leukemia and a commercial packing containing said combination.
EFFECT: composition shows high efficacy.
9 cl, 16 dwg, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATIONS CONTAININS Bcr-Abl/c-Kit/PDGF-RTK INHIBITORS FOR TREATING CANCER | 2007 |
|
RU2452492C2 |
| COMBINATION OF MCL-1 INHIBITOR AND MIDOSTAURIN, ITS APPLICATIONS AND PHARMACEUTICAL COMPOSITIONS | 2019 |
|
RU2818453C2 |
| KINASES MODULATION AND INDICATIONS FOR ITS USE | 2012 |
|
RU2631487C2 |
| INDOLE DERIVATIVES AS HISTAMINE RECEPTOR ANTAGONISTS | 2005 |
|
RU2382778C2 |
| IAP INHIBITORS | 2005 |
|
RU2425838C2 |
| INDOLE-3-YL-CARBONYL-SPIRO-PIPERIDINE DERIVATIVES | 2006 |
|
RU2420529C2 |
| SUBSTITUTED BICYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF INHIBITION | 1998 |
|
RU2204557C2 |
| SUBSTITUTED NICOTINAMIDES AS KCNQ2-3 MODULATORS | 2010 |
|
RU2529904C2 |
| SUBSTITUTED AROMATIC DERIVATIVE WITH CONDENSED RINGS AND COMPOSITION INCLUDING IT AND THEIR USE | 2020 |
|
RU2811484C1 |
| SUBSTITUTED DERIVATIVES OF CYCLOHEXAN-1,4-DIAMINE, METHOD FOR THEIR PREPARING AND DRUG | 2002 |
|
RU2321579C2 |
